Large-scale testing (Phase 3)Study completedNCT00160706
What this trial is testing
A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease
Who this might be right for
Crohn's Disease
UCB Pharma SA 310